Clinical trials: Patients With Ultra High Risk of Psychotic Transition, open to volunteers
Patients With Ultra High Risk of Psychotic Transition
Evaluation of Membrane Phospholipid and Energy Metabolism in Subjects at High Risk of Psychotic Transition
The management of schizophrenia is a major public health issue, due to its particularly disabling psychotic symptoms and their onset at an early age, typically in adolescents or young adults.
- Trial name
- MR7T-UHR (NCT05865652)
- Testing
- Cerebral MRI with Phosphorus 31 Magnetic Resonance Spectroscopy
- Where
- France
- Volunteers
- 22 people, healthy volunteers welcome
- Sponsor
- Centre Hospitalier Henri Laborit